Detalles de la búsqueda
1.
S100ß as a serum marker in endocrine resistant breast cancer.
BMC Med
; 15(1): 79, 2017 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28399921
2.
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities.
Nat Commun
; 13(1): 514, 2022 01 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35082299
3.
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype.
Oncogene
; 40(7): 1318-1331, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33420368
4.
Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence.
Clin Cancer Res
; 15(6): 2098-106, 2009 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19276281
5.
The microtubule-targeting agents, PBOX-6 [pyrrolobenzoxazepine 7-[(dimethylcarbamoyl)oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine] and paclitaxel, induce nucleocytoplasmic redistribution of the peptidyl-prolyl isomerases, cyclophilin A and pin1, in malignant hematopoietic cells.
J Pharmacol Exp Ther
; 329(1): 38-47, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19131583
6.
Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to Therapy.
Mol Cancer Ther
; 18(10): 1731-1743, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31289138
7.
Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy.
Clin Cancer Res
; 21(23): 5371-9, 2015 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26240272
8.
NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis.
Cancer Res
; 74(13): 3477-88, 2014 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24769444
Resultados
1 -
8
de 8
1
Próxima >
>>